Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-016802
Filing Date
2025-05-14
Accepted
2025-05-14 15:18:32
Documents
58
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q inbp20250331_10q.htm   iXBRL 10-Q 1155568
2 EXHIBIT 31.1 CERTIFICATION OF CO-CEOS ex_804424.htm EX-31.1 13550
3 EXHIBIT 31.2 CERTIFICATION OF CFO ex_804425.htm EX-31.2 15160
4 EXHIBIT 32.1 CERTIFICATION OF CO-CEOS PURSUANT TO 906 ex_804426.htm EX-32.1 9108
5 EXHIBIT 32.2 CERTIFICATION OF CFO PURSUANT SECTION 906 ex_804427.htm EX-32.2 7181
  Complete submission text file 0001437749-25-016802.txt   5845783

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA inbp-20250331.xsd EX-101.SCH 45816
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inbp-20250331_cal.xml EX-101.CAL 40131
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inbp-20250331_def.xml EX-101.DEF 315021
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE inbp-20250331_lab.xml EX-101.LAB 287228
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inbp-20250331_pre.xml EX-101.PRE 339258
61 EXTRACTED XBRL INSTANCE DOCUMENT inbp20250331_10q_htm.xml XML 1034031
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

EIN.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31668 | Film No.: 25944820
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)